loader
Page is loading...
OVERVIEW

Jim F. Murdica
Partner

Los Angeles

2029 Century Park East
Suite 300
Los Angeles, CA 90067

Chicago

One North Wacker Drive
Suite 4400
Chicago, IL 60606-2833

New York

445 Park Avenue
Suite 700
New York, NY 10022-8634

P 312-214-4869

F 310-284-3894

OVERVIEW

Jim F. Murdica
Partner

Los Angeles

2029 Century Park East
Suite 300
Los Angeles, CA 90067

Chicago

One North Wacker Drive
Suite 4400
Chicago, IL 60606-2833

New York

445 Park Avenue
Suite 700
New York, NY 10022-8634

P 312-214-4869

F 310-284-3894

Jim Murdica is co-chair of the Drug and Medical Device Practice Group. Since 2016, Jim has been recognized by Chambers USA for his work in product liability and mass tort in the nationwide category.

OVERVIEW

Jim Murdica is co-chair of the Drug and Medical Device Practice Group. Since 2016, Jim has been recognized by Chambers USA for his work in product liability and mass tort in the nationwide category.

Jim's practice focuses on the defense of pharmaceutical, medical device and consumer product litigation in state and federal courts nationwide, particularly consolidated mass torts and multi-district litigations.

He serves as national coordinating counsel and MDL counsel for coordinated or consolidated litigations across the U.S. involving thousands of plaintiffs as well as in numerous single-plaintiff cases involving prescription pharmaceuticals, consumer products and medical devices. In conjunction with those roles, Jim emphasizes efficient discovery in his practice and manages significant mass tort e-discovery undertakings for his clients utilizing proactive and progressive strategies.

Jim also counsels clients on product liability due diligence related to potential acquisitions and divestitures.

Regarding pharmaceutical and biologic manufacturers, Jim's experience includes:

  • Coordinating the national defense and acting as MDL counsel for the defense of several thousand litigations and claims alleging serious nervous system and vascular injuries from the use of a prescription antibiotic
  • Coordinating the national defense of hundreds of consolidated litigations alleging birth defects from exposure to an anticonvulsant medication in the Philadelphia Mass Torts Division
  • Coordinating the defense of consolidated state litigations in California alleging a life-threatening skin condition and tendon injuries from the use of a prescription antibiotic
  • Defending or assisting in the defense of consolidated and single plaintiff litigations regarding: anticoagulant medication, antidiabetic mediation, antipsychotic medications, antiepileptic medication, antibiotic medications, and various biologics that inhibit factors and bind proteins

Regarding medical device and consumer products manufacturers, Jim's experience includes:

  • Coordinating the national defense and serving as MDL counsel in the defense of a laparoscopic gynecologic surgical instrument for a medical device manufacturer
  • Coordinating the national defense of several hundred litigants and serving as lead counsel in a consolidated state proceeding regarding vena cava filters for a medical device manufacturer
  • Coordinating the national defense of contact lenses and vision devices for multiple medical device manufacturers
  • Coordinating the national defense of personal injury litigations for a cardiac catheter manufacturer
  • Defending the manufacturer of cardiac stents in a nationwide litigation alleging personal injuries from use of the device
  • Acting as national counsel for a manufacturer of skincare products

Jim is not regularly admitted to practice in the local courts of Illinois.

EXPERIENCE
Publications and Presentations
  • 'New Drug Application Conflict Preemption Defense Gains Traction in Utts' BT Product Liability Blog, February 10, 2017 (Author) *republished in The National Law Review
  • 'Tools for the 'New World' of eDiscovery and Information Governance' Barnes & Thornburg CLE, December 14, 2016 (Speaker)
  • "A Practical Guide to Using Tools in the Defense Arsenal to Fight Litigation Tourism and Frivolous Litigation" ACI Annual Drug & Medical Device Litigation conference, December 6, 2016 (Speaker)
  • 'Preserving the Medical Device Preemption Defense in Light of Contrary Court Decisions and a Resurgence of Off-Label Attacks' ACI Annual Drug & Medical Device Litigation conference, December 3, 2015 (Panelist)
  • 'How to Streamline eDiscovery' The Masters Conference, July 16, 2015 (Panelist)
  • 'Off-Label Treatment: Use of Cancer Drugs Outside of Conventional Trials and Government Approvals' JALBCA Symposium, November 20, 2014 (Panelist)
  • 'The Biomaterials Access Assurance Act: An Underused Tool Against Forum Shopping' DRI For The Defense, September, 2014 (Co-Author)
  • 'Product Liability ' Case Law Update 2014' DRI Case Law Update, 2014 (Author)
  • 'Formulating Your Device Defense from Day One: Evolving Regulations and Online Resources' DRI Drug and Medical Device Seminar, May 17, 2013 (Speaker)
  • 'Product Liability ' Case Law Update 2010' DRI Case Law Update, 2010 (Author)
INSIGHTS & EVENTS
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.